Clinical trial
Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving…
NCT00006481 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006481 |
|---|---|
| Title | Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer |
| Official title | A Phase III Comparison of Biafine to Declared Institutional Preference for Radiation Induced Skin Toxicity in Patients Undergoing Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Biafine cream, quality-of-life assessment, radiation therapy |
| Start date | Oct 1, 2000 |
| Primary completion | Aug 1, 2002 |
| First posted | Dec 31, 2003 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: